ATE250420T1 - Verwendung von uridin-triphosphat verwandte verbidungen zur prävention und behandlung von pneumonie in immobilisieren patienten - Google Patents
Verwendung von uridin-triphosphat verwandte verbidungen zur prävention und behandlung von pneumonie in immobilisieren patientenInfo
- Publication number
- ATE250420T1 ATE250420T1 AT97934275T AT97934275T ATE250420T1 AT E250420 T1 ATE250420 T1 AT E250420T1 AT 97934275 T AT97934275 T AT 97934275T AT 97934275 T AT97934275 T AT 97934275T AT E250420 T1 ATE250420 T1 AT E250420T1
- Authority
- AT
- Austria
- Prior art keywords
- airways
- secretions
- patient
- mucous
- utp
- Prior art date
Links
- PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 title abstract 4
- PGAVKCOVUIYSFO-UHFFFAOYSA-N uridine-triphosphate Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 title abstract 4
- 206010035664 Pneumonia Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229950010342 uridine triphosphate Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 230000028327 secretion Effects 0.000 abstract 4
- 230000035559 beat frequency Effects 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 230000001886 ciliary effect Effects 0.000 abstract 2
- 230000004936 stimulating effect Effects 0.000 abstract 2
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 abstract 1
- YDHWWBZFRZWVHO-UHFFFAOYSA-H [oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O YDHWWBZFRZWVHO-UHFFFAOYSA-H 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 210000004081 cilia Anatomy 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- 229940012356 eye drops Drugs 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000000887 hydrating effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000006194 liquid suspension Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000007923 nasal drop Substances 0.000 abstract 1
- 229940100662 nasal drops Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08685216 US5763447C1 (en) | 1996-07-23 | 1996-07-23 | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| PCT/US1997/012938 WO1998003182A2 (en) | 1996-07-23 | 1997-07-23 | Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE250420T1 true ATE250420T1 (de) | 2003-10-15 |
Family
ID=24751220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97934275T ATE250420T1 (de) | 1996-07-23 | 1997-07-23 | Verwendung von uridin-triphosphat verwandte verbidungen zur prävention und behandlung von pneumonie in immobilisieren patienten |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5763447C1 (de) |
| EP (1) | EP0938322B1 (de) |
| JP (1) | JP2000516581A (de) |
| KR (1) | KR20000067983A (de) |
| CN (1) | CN1226169A (de) |
| AT (1) | ATE250420T1 (de) |
| AU (1) | AU727790B2 (de) |
| CA (1) | CA2261674A1 (de) |
| DE (1) | DE69725160T2 (de) |
| NZ (1) | NZ334204A (de) |
| WO (1) | WO1998003182A2 (de) |
| ZA (1) | ZA976538B (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5900407A (en) * | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
| US6319908B1 (en) | 1996-07-03 | 2001-11-20 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof |
| US5968913A (en) * | 1996-07-03 | 1999-10-19 | Inspire Pharmaceuticals, Inc. | Pharmaceutical compositions of uridine triphosphate |
| US5763447C1 (en) * | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| US6921755B2 (en) | 1998-02-06 | 2005-07-26 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with purinergic receptor agonists |
| US6696425B2 (en) | 1997-02-06 | 2004-02-24 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with purinergic receptor agonists |
| EP0981534B1 (de) | 1997-02-06 | 2006-05-03 | Inspire Pharmaceuticals, Inc. | Dinukleotide und ihre verwendungen |
| US7223744B2 (en) * | 1997-02-10 | 2007-05-29 | Inspire Pharmaceuticals, Inc. | Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof |
| US6872710B2 (en) * | 1997-07-25 | 2005-03-29 | Inspire Pharmaceuticals, Inc. | Di(uridine 5′)-tetraphosphate and salts thereof |
| TW593331B (en) | 1997-07-25 | 2004-06-21 | Inspire Pharmaceuticals Inc | Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof |
| CA2295515C (en) * | 1997-07-25 | 2006-03-14 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof |
| US6462028B2 (en) | 1997-07-25 | 2002-10-08 | Inspire Pharmaceuticals, Inc. | Method of promoting cervical and vaginal secretions |
| US6548658B2 (en) * | 1997-07-25 | 2003-04-15 | Inspire Pharmaceuticals, Inc. | Di-(uridine 5′)-tetraphosphate and salts thereof |
| WO1999063927A1 (en) * | 1998-06-08 | 1999-12-16 | Michael Lansdale | System and method for acupressure therapy |
| CN100354296C (zh) * | 1998-10-02 | 2007-12-12 | 雅玛山酱油株式会社 | 二尿苷四磷酸或其盐的晶体和其制备方法、以及制备该化合物的方法 |
| EP1043329B1 (de) * | 1998-10-02 | 2002-08-28 | Yamasa Corporation | Ein kristall von diuridine tetraphosphat oder ein solches salz und verfahren zu seiner herstellung, verfahren und herstellung der vorgenannten zusammensetzung |
| US6864243B1 (en) | 2000-05-12 | 2005-03-08 | Inspire Pharmaceuticals, Inc. | Method for treating retinal degeneration with purinergic receptor agonists |
| US7132408B2 (en) | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
| US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| DE10108851A1 (de) * | 2001-02-23 | 2002-09-12 | Resprotect Gmbh | Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten |
| WO2003000056A1 (en) | 2001-06-25 | 2003-01-03 | Inspire Pharmaceuticals, Inc. | Joint lubrication with p2y purinergic receptor agonists |
| MXPA04004215A (es) * | 2001-11-06 | 2004-07-08 | Inspire Pharmaceuticals Inc | Metodo para el tratamiento o la prevencion de enfermedades inflamatorias. |
| US7607436B2 (en) * | 2002-05-06 | 2009-10-27 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
| US7334580B2 (en) * | 2002-05-07 | 2008-02-26 | Smaldone Gerald C | Methods, devices and formulations for targeted endobronchial therapy |
| GB0417886D0 (en) * | 2004-08-11 | 2004-09-15 | Univ Cardiff | Method and means for enhanced pulmonary delivery |
| US7368439B2 (en) * | 2005-06-15 | 2008-05-06 | Bar - Ilan University | Dinucleoside poly(borano)phosphate derivatives and uses thereof |
| US7851456B2 (en) * | 2005-06-29 | 2010-12-14 | Inspire Pharmaceuticals, Inc. | P2Y6 receptor agonists for treating lung diseases |
| US8288545B2 (en) * | 2006-07-21 | 2012-10-16 | Glsynthesis Inc. | Reactive pyrophosphoric and bisphosphonic acid derivatives and methods of their use |
| JP2008199905A (ja) * | 2007-02-16 | 2008-09-04 | Snow Brand Milk Prod Co Ltd | 乳酸菌生残性向上剤 |
| US8618074B2 (en) * | 2007-03-15 | 2013-12-31 | Board Of Regents Of The University Of Texas System | GPCR enhanced neuroprotection to treat brain injury |
| CA2747188C (en) | 2008-11-20 | 2017-06-13 | Glsynthesis Inc. | Antithrombotic diadenosine tetraphosphates and related analogs |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2016195072A1 (ja) * | 2015-06-05 | 2016-12-08 | 参天製薬株式会社 | ソフトコンタクトレンズが装用されたドライアイ患者の眼に点眼されるように用いられることを特徴とするドライアイ治療剤 |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| WO2019053746A1 (en) * | 2017-09-17 | 2019-03-21 | Glenn Fernandes | APPARATUS AND METHOD FOR PULMONARY CLEANING |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9027968D0 (en) * | 1990-12-22 | 1991-02-13 | Fisons Plc | Method of treatment |
| FR2677250B1 (fr) * | 1991-06-05 | 1995-01-20 | Synthelabo | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique. |
| FR2684299B1 (fr) * | 1991-12-02 | 1995-03-24 | Synthelabo | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride. |
| EP0517573A1 (de) * | 1991-06-05 | 1992-12-09 | Synthelabo | Pharmazeutische Zusammensetzungen zur Behandlung von Atemwegserkrankungen |
| US5292498A (en) | 1991-06-19 | 1994-03-08 | The University Of North Carolina At Chapel Hill | Method of treating lung disease with uridine triphosphates |
| WO1995010538A1 (en) | 1993-10-15 | 1995-04-20 | The University Of North Carolina At Chapel Hill | Dna encoding the human p2u receptor and null cells expressing p2u receptors |
| US5656256A (en) | 1994-12-14 | 1997-08-12 | The University Of North Carolina At Chapel Hill | Methods of treating lung disease by an aerosol containing benzamil or phenamil |
| US5635160A (en) | 1995-06-07 | 1997-06-03 | The University Of North Carolina At Chapel Hill | Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
| US5628984A (en) | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
| JP3519199B2 (ja) | 1996-02-06 | 2004-04-12 | 株式会社ソニー・コンピュータエンタテインメント | 画像生成装置 |
| US6420347B1 (en) * | 1997-03-27 | 2002-07-16 | Inspire Pharmaceuticals, Inc. | Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| US5837861A (en) | 1997-02-10 | 1998-11-17 | Inspire Pharmaceuticals, Inc. | Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| US5900407A (en) | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
| NZ332426A (en) | 1996-03-27 | 2000-09-29 | Univ North Carolina | Method of treating diseases involving dysfunction of ciliary movement such as ciliary dyskinesia and infertility with uridine triphosphates (UTP) and related compounds |
| US5968913A (en) | 1996-07-03 | 1999-10-19 | Inspire Pharmaceuticals, Inc. | Pharmaceutical compositions of uridine triphosphate |
| US6319908B1 (en) * | 1996-07-03 | 2001-11-20 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof |
| US5789391A (en) | 1996-07-03 | 1998-08-04 | Inspire Pharmaceuticals, Inc. | Method of treating sinusitis with uridine triphosphates and related compounds |
| US5962432A (en) * | 1996-07-03 | 1999-10-05 | Inspire Pharmaceuticals, Inc. | Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate |
| US5763447C1 (en) | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| WO1998015835A1 (en) | 1996-10-08 | 1998-04-16 | Inspire Pharmaceuticals, Inc. | Method of early lung cancer detection via sputum induction and analysis of sputum to detect cancer associated substances |
| US6159952A (en) | 1996-11-07 | 2000-12-12 | Inspire Pharmaceuticals, Inc. | Method of treating bronchitis with uridine triphosphate and related compounds |
| EP0981534B1 (de) | 1997-02-06 | 2006-05-03 | Inspire Pharmaceuticals, Inc. | Dinukleotide und ihre verwendungen |
| US6462028B2 (en) | 1997-07-25 | 2002-10-08 | Inspire Pharmaceuticals, Inc. | Method of promoting cervical and vaginal secretions |
| CA2295515C (en) | 1997-07-25 | 2006-03-14 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof |
| BR9811612A (pt) | 1997-08-29 | 2000-08-08 | Univ North Carolina | Uso de 5' -difosfato de uridina e similares para tratamento de doenças pulmonares |
| DE69905464T2 (de) | 1998-05-22 | 2004-01-15 | Inspire Pharmaceuticals Inc | Therapeutische dinucleotide und deren derivate |
| EP1140967A1 (de) | 1998-12-23 | 2001-10-10 | University Of North Carolina At Chapel Hill | Gezielter gentransfer unter verwendung von an g-protein gekoppelten rezeptoren |
| KR20010114214A (ko) | 1999-02-26 | 2001-12-31 | 인스파이어 파마슈티컬스 인코퍼레이티드 | 우리딘, 아데닌 및 시티딘 디포스페이트 및 그의 유사체에의한 점막수화 촉진방법 |
| US6555675B2 (en) * | 2000-08-21 | 2003-04-29 | Inspire Pharmaceuticals, Inc. | Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists |
-
1996
- 1996-07-23 US US08685216 patent/US5763447C1/en not_active Expired - Lifetime
-
1997
- 1997-07-23 AU AU37375/97A patent/AU727790B2/en not_active Ceased
- 1997-07-23 NZ NZ334204A patent/NZ334204A/en unknown
- 1997-07-23 ZA ZA976538A patent/ZA976538B/xx unknown
- 1997-07-23 WO PCT/US1997/012938 patent/WO1998003182A2/en not_active Ceased
- 1997-07-23 DE DE69725160T patent/DE69725160T2/de not_active Expired - Fee Related
- 1997-07-23 JP JP10507210A patent/JP2000516581A/ja active Pending
- 1997-07-23 KR KR1019997000504A patent/KR20000067983A/ko not_active Withdrawn
- 1997-07-23 AT AT97934275T patent/ATE250420T1/de not_active IP Right Cessation
- 1997-07-23 EP EP97934275A patent/EP0938322B1/de not_active Expired - Lifetime
- 1997-07-23 CA CA002261674A patent/CA2261674A1/en not_active Abandoned
- 1997-07-23 CN CN97196639A patent/CN1226169A/zh active Pending
- 1997-07-23 US US09/202,825 patent/US6703376B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69725160D1 (de) | 2003-10-30 |
| US5763447C1 (en) | 2002-05-07 |
| US5763447A (en) | 1998-06-09 |
| WO1998003182A3 (en) | 1998-05-14 |
| US20020155150A1 (en) | 2002-10-24 |
| NZ334204A (en) | 2000-07-28 |
| WO1998003182A2 (en) | 1998-01-29 |
| CN1226169A (zh) | 1999-08-18 |
| DE69725160T2 (de) | 2004-08-12 |
| JP2000516581A (ja) | 2000-12-12 |
| KR20000067983A (ko) | 2000-11-25 |
| CA2261674A1 (en) | 1998-01-29 |
| ZA976538B (en) | 1998-07-09 |
| US6703376B2 (en) | 2004-03-09 |
| EP0938322B1 (de) | 2003-09-24 |
| AU727790B2 (en) | 2000-12-21 |
| EP0938322A2 (de) | 1999-09-01 |
| AU3737597A (en) | 1998-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5763447C1 (en) | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds | |
| DE69716255D1 (de) | Verfahren zur behandlung von mittelohrentzündung mittels uridintriphosphaten und verwandten mitteln | |
| Carlisle | Silicon | |
| US4556557A (en) | Method and composition for combating snoring, and the use of surface active substances for the preparation of said composition | |
| DE69736468D1 (de) | Verfahren zur behandlung der ziliardyskinesie mit uridintriphosphaten und verwandten verbindungen | |
| ATE231519T1 (de) | Dinukleotide zur verwendung in der behandlung von lungenkrankheiten | |
| NO992197L (no) | FremgangsmÕte for behandling av bronkitt med uridintrifosfater og relaterte forbindelser | |
| NZ313864A (en) | Method of obtaining a mucous sample from the lung using triphosphate compounds | |
| DE69903750D1 (de) | Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten | |
| CA2240717A1 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
| JPH0656672A (ja) | 気道障害治療のための医薬組成物 | |
| ATE289800T1 (de) | Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems | |
| JP2019532933A5 (de) | ||
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| EE04330B1 (et) | Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks | |
| JP2002506009A (ja) | 呼吸器疾患および中耳炎の治療 | |
| ATE91890T1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
| RU95116663A (ru) | Способ лечения острых респираторных вирусных заболеваний и гриппа | |
| SU1536534A1 (ru) | Способ лечения острого панкреатита | |
| MXPA98002276A (en) | New therapeutic compositions based on silicon biologically act | |
| UA36166A (uk) | Спосіб лікування запальних захворювань підшлункової залози | |
| JPH10203988A (ja) | 鼻茸および鼻粘膜の浮腫性病変の治療剤 | |
| KR840002006A (ko) | 포스포르아미드 유도체, 그의 제법 및 그것을 함유하는 의약 | |
| RU95104044A (ru) | Способ лечения инфекционных заболеваний верхних дыхательных путей, легких и бронхов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |